D-Stat® Dry Topical Hemostat

The D-Stat® Dry Topical Hemostat is applied topically as an adjunct to manual compression and is indicated for the control of surface bleeding from vascular access sites and percutaneous catheters or tubes and reducing the time-to-hemostasis in patients undergoing diagnostic endovascular procedures utilizing 4–6 Fr. introducer sheaths. The D-Stat® Dry Silver Topical Hemostat is applied topically as an adjunct to manual compression and is indicated for the control of surface bleeding from vascular access sites and percutaneous catheters or tubes and reducing the time-to-hemostasis in patients undergoing diagnostic endovascular procedures utilizing 4-6 Fr. introducer sheaths. D-Stat Dry Silver® Topical Hemostat contains silver chloride to prevent microorganisms commonly encountered in the clinical setting from colonizing on the pad Thrombix® and Thrombix® Silver Topical Hemostat is applied topically as an adjunct to manual compression and is indicated for the control of surface bleeding from vascular access sites and percutaneous catheters or tubes. Thrombix® Silver Topical Hemostat contains silver chloride to prevent microorganisms commonly encountered in the clinical setting from colonizing on the pad. The D-Stat® Dry, D-Stat® Dry Silver, Thrombix® and Thrombix® Silver Topical Hemostat are contraindicated in persons with known sensitivity to bovine-derived materials.

WARNING: SEVERE BLEEDING AND THROMBOSIS COMPLICATIONS
- THROMBIN-JMI^® can cause fatal severe bleeding or thrombosis. Thrombosis may result from the development of antibodies against bovine thrombin. Bleeding may result from the development of antibodies against factor V. These may cross-react with human factor V and lead to its deficiency.
- Do not re-expose patients to THROMBIN-JMI^® if there are known or suspected antibodies to bovine thrombin and/or factor V.
- Monitor patients for abnormal coagulation laboratory values, bleeding, or thrombosis.